Chromosome 11-14 translocation
Chromosome 11-14 translocation is a genetic condition characterized by an abnormal rearrangement between chromosome 11 and chromosome 14. This translocation is of particular interest in the field of genetics and medicine due to its association with various types of cancer, most notably certain forms of lymphoma, including Mantle Cell Lymphoma (MCL).
Overview[edit | edit source]
In a normal cell, chromosomes are structures that carry DNA and are found in pairs. Humans have 23 pairs of chromosomes. A translocation is a type of chromosomal abnormality where a segment from one chromosome is transferred to another chromosome. The chromosome 11-14 translocation involves the exchange of genetic material between the long arms (q arms) of chromosomes 11 and 14, denoted as t(11;14)(q13;q32).
Causes[edit | edit source]
The exact cause of chromosome 11-14 translocation is not fully understood. However, it is known to occur randomly and can be acquired during a person's lifetime. This means it is not inherited from parents but develops in a single cell after conception. This type of mutation is referred to as a somatic mutation.
Pathophysiology[edit | edit source]
The translocation between chromosomes 11 and 14 results in the juxtaposition of the IGH gene on chromosome 14 and the BCL-1 (B-cell lymphoma/leukemia 1) gene cluster on chromosome 11. This rearrangement leads to the overexpression of cyclin D1, a protein that is crucial for cell cycle progression. The overproduction of cyclin D1 promotes uncontrolled cell division, which can lead to the development of cancer, particularly lymphoma.
Clinical Significance[edit | edit source]
The chromosome 11-14 translocation is most commonly associated with Mantle Cell Lymphoma (MCL), a type of non-Hodgkin lymphoma. This genetic marker is present in the majority of MCL cases and is used as a diagnostic criterion. The presence of this translocation can influence the prognosis and treatment strategies for patients with MCL.
Diagnosis[edit | edit source]
The diagnosis of chromosome 11-14 translocation is typically made using cytogenetic techniques such as Fluorescence In Situ Hybridization (FISH) or Polymerase Chain Reaction (PCR). These methods allow for the detection of the specific genetic rearrangement in tumor cells.
Treatment[edit | edit source]
The treatment for conditions associated with chromosome 11-14 translocation, such as MCL, involves a combination of chemotherapy, immunotherapy, and sometimes stem cell transplantation. The choice of treatment depends on various factors, including the stage of the disease, the patient's overall health, and the presence of other genetic abnormalities.
Conclusion[edit | edit source]
Chromosome 11-14 translocation is a significant genetic abnormality with implications for the diagnosis and treatment of certain cancers, particularly Mantle Cell Lymphoma. Ongoing research into the mechanisms and effects of this translocation may lead to improved diagnostic techniques and targeted therapies for affected individuals.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD